| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/12/1999 | US5859184 Alpha-helix mimetics and methods relating thereto |
| 01/12/1999 | US5859031 Small molecule inhibitors of rotamase enzyme activity |
| 01/12/1999 | US5859002 HIV protease inhibitors |
| 01/12/1999 | US5858994 Carbohydrate conjugates as inhibitors of cell adhesion |
| 01/12/1999 | US5858982 Cathepsin and methods and compositions for inhibition thereof |
| 01/12/1999 | US5858979 Anticoagulant peptides |
| 01/12/1999 | US5858660 Parallel selex |
| 01/07/1999 | WO1999032511A1 PEPTIDES, METHOD FOR ASSAYING HUMAN PEPSINOGEN II or HUMAN PEPSIN II, AND ASSAYING KIT |
| 01/07/1999 | WO1999000361A1 Ace-inhibitor nitric salts |
| 01/07/1999 | EP0889036A1 HIV protease inhibitors |
| 01/07/1999 | EP0888459A1 Measurement of complement activation by biomaterials by means of complement convertase cleavage of peptide substrates |
| 01/07/1999 | EP0888381A1 Targeted therapeutic or diagnostic agents and methods of making and using same |
| 01/07/1999 | EP0888130A2 New ternary radiopharmaceutical complexes |
| 01/07/1999 | CA2292794A1 Ace-inhibitor nitric salts |
| 01/06/1999 | CN1204341A Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting release of growth hormone |
| 01/06/1999 | CN1041524C Oligopeptides derived from C-reactive protein fragments and its medical composition |
| 01/05/1999 | US5856530 Antipicornaviral compounds and methods for their use and preparation |
| 01/05/1999 | US5856477 Hypotensive agents; congestive heart failure |
| 01/05/1999 | US5856476 Processes for preparing azepiones useful as intermediates in the preparation of inhibitors of angiotensin converting enzyme and neutral endopeptidase |
| 01/05/1999 | US5856474 Cephalosporin synthesis |
| 01/05/1999 | US5856439 Farnesyl transferase inhibitors, preparation thereof, and pharmaceutical compositions containing same |
| 01/05/1999 | US5856353 Sulfonamide inhibitors of aspartyl protease |
| 01/05/1999 | US5856310 Inhibition of farnesyltransferase |
| 01/05/1999 | US5856309 Treating osteoporosis, inflammation or a disease which is due to a thromboembolic event |
| 01/05/1999 | US5856307 Peptide derivatives as kininogenase inhibitors |
| 01/05/1999 | US5856306 Oligopeptides modified with boron fragment |
| 12/30/1998 | WO1998058950A1 Compounds with growth hormone releasing properties |
| 12/30/1998 | WO1998058949A1 Treatment of insulin resistance with growth hormone secretagogues |
| 12/30/1998 | WO1998058948A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 12/30/1998 | WO1998058947A1 Dipeptide derivatives as growth hormone secretagogues |
| 12/30/1998 | EP0887354A2 Process of working up of 1- N2-((S)-ethoxycarbonyl)-3-phenylpropyl)-N6-trifluor-acetyl -L-lysyl-L-prolin (Lisinopril(Tfa)ethylester, LPE) |
| 12/30/1998 | EP0886647A1 Serine protease inhibitors |
| 12/30/1998 | EP0705105A4 Metal chelates as spacer compounds in biologically active peptides |
| 12/30/1998 | CN1203602A Acylated enol derivatives of 'alpha'-ketoesters and 'alpha'-ketoamides |
| 12/30/1998 | CA2294464A1 Treatment of insulin resistance |
| 12/29/1998 | US5854388 Angiotensin IV peptides and receptor |
| 12/29/1998 | US5854249 Opioid diarylmethylpiperazines and piperidines |
| 12/29/1998 | US5854211 Compounds with growth hormone releasing properties |
| 12/29/1998 | US5854029 Method for preparing antihypertensive agent |
| 12/29/1998 | US5853713 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units |
| 12/29/1998 | US5853623 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
| 12/24/1998 | DE19827309A1 Tri:fluoro:acetyl lisinopril ethyl ester purification |
| 12/23/1998 | EP0885904A1 Peptides as agonists and/or inhibitors of amyloid formation and/or cytotoxicity and their use against Alzheimer's disease, type II diabetes mellitus and spongiform encephalopathy |
| 12/23/1998 | EP0885887A2 Sulfonamide inhibitors of HIV-Aspartyl protease |
| 12/23/1998 | EP0885608A1 Remedies for brain diseases |
| 12/23/1998 | EP0885243A1 Crystal structure of apopain and uses thereof |
| 12/23/1998 | EP0885189A2 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 12/23/1998 | EP0885188A1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
| 12/23/1998 | EP0885186A1 Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 12/23/1998 | EP0722459B1 Hemoregulatory penta- or hexapeptides |
| 12/23/1998 | CN1202902A Thrombin inhibitors |
| 12/23/1998 | CN1202901A Phosphonic acid derivatives with metallopeptidase inhibitory activity |
| 12/23/1998 | CN1202882A New LH-RH antigonists with improved effectiveness |
| 12/23/1998 | CN1041281C Polymer-bound taxol derivatives |
| 12/22/1998 | US5852051 Dipeptide p-amidinobenzylamides with N-terminal sulfonyl or aminosulfonyl radicals |
| 12/22/1998 | US5852045 Fibrinogen receptor antagonists |
| 12/22/1998 | US5852043 HIV protease inhibitors |
| 12/17/1998 | WO1998057174A1 Synthetic antibiotics |
| 12/17/1998 | WO1998051325A3 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 12/17/1998 | CA2240005A1 Peptides acting as agonists and inhibitors of amyloid formation and cytotoxicity for therapeutic use with alzeheimer's disease, type ii diabetes mellitus and spongiform encephalopathies |
| 12/16/1998 | EP0884326A2 Antithrombitic compound |
| 12/16/1998 | EP0884325A1 Thrombin inhibitors containing a peptidyl heterocycle |
| 12/16/1998 | EP0883629A1 Oligopeptides for drug delivery |
| 12/16/1998 | EP0715618B1 Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors |
| 12/16/1998 | CN1202174A Peptide derivatives |
| 12/16/1998 | CN1202161A Macrocyclic compounds as metalloprotease inhibitors |
| 12/16/1998 | CN1041205C Process for crystallisation of aspartame |
| 12/15/1998 | US5849954 Method of peptide synthesis |
| 12/15/1998 | US5849918 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 12/15/1998 | US5849908 Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 12/15/1998 | US5849893 Nucleic acid-binding oligomers possessing C-branching for therapy and diagnostics |
| 12/15/1998 | US5849866 Peptidase inhibitors |
| 12/15/1998 | US5849865 Peptides for altering bone resorption, angiogenesis and restenosis |
| 12/15/1998 | US5849711 Cathepsin and methods and compositions for inhibition thereof |
| 12/15/1998 | US5849710 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors |
| 12/15/1998 | US5849693 Cyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein IIb/IIIa |
| 12/15/1998 | US5849691 Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II |
| 12/15/1998 | US5849690 Anti-aggregatory peptides |
| 12/15/1998 | US5849510 Factor Xa inhibitors |
| 12/15/1998 | US5849296 Crosslinked protein crystals |
| 12/15/1998 | US5849260 Technetium-99M labeled peptides for thrombus imaging |
| 12/15/1998 | CA1340227C L-proline derivatives; process for preparing them and biological uses |
| 12/15/1998 | CA1340186C Peptides |
| 12/10/1998 | WO1998055503A1 Method for preparing salts of aspartame from n-protected aspartame |
| 12/10/1998 | WO1998055449A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties |
| 12/09/1998 | EP0882228A1 Methods to identify modulators of cell signaling |
| 12/09/1998 | EP0882128A1 Cell-based assay |
| 12/09/1998 | EP0882066A1 Peptide derivatives |
| 12/09/1998 | EP0751779A4 Selectively cleavable linkers based on iminodiacetic acid ester bonds |
| 12/09/1998 | CN1201459A Novel pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising same as active ingredient |
| 12/09/1998 | CN1201454A Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 12/08/1998 | US5847192 Boronic compound complexing reagents and complexes |
| 12/08/1998 | US5847135 Inhibitors of interleukin-1β converting enzyme |
| 12/08/1998 | US5847121 Production of nitro-benzyl-dota via direct peptide cyclization |
| 12/08/1998 | US5847117 Reagent and catalytic process useful for cleaving a protected functional group |
| 12/08/1998 | US5846987 Retroviral protease inhibiting compounds |
| 12/08/1998 | US5846942 Cholecystokinin antagonists, their preparation and therapeutic use |
| 12/08/1998 | US5846941 Isosteric antiherpes peptide derivatives II |
| 12/08/1998 | US5846940 Corneal therapeutic agent |
| 12/08/1998 | US5846755 Method for determining the therapeutic activity of metalloproteinase inhibitor compounds |